Aicuris Anti-Infective Cures AG

Aicuris Anti-Infective Cures AG is a company in Wuppertal, Germany that has taken part in 6 EU-funded projects since 2015, receiving €249k in EU funding.

EU funding received€249k
EU projects6
As coordinator0
Running now1
First EU project2015
Latest project2024
CountryGermany
EU registration (PIC)924592070
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Aicuris Anti-Infective Cures AG's own share of each project, not the project's full budget.

  • Horizon 2020€249k · 3 projects
  • Horizon Europe€0 · 2 projects
  • FP7 (2007 to 2013)€0 · 1 project

Projects

6 EU-funded projects, newest first. Each links to the official record.

  • NAKED-CAssociated partner

    New late-stage functionalization reagents for the construction of chiral centers to impact drug discoveryhis her

    Horizon Europe · 2024–2026 · Project on CORDIS ↗

  • BREAKthroughPartner

    Breaking the barrier - An integrated multidisciplinary approach to kill Gram-negative bacteria through existing antibiotics by making their outer membrane permeable

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

  • CAREPartner

    Corona Accelerated R&D in Europe

    Horizon 2020 · 2020–2025 · Project on CORDIS ↗

  • VIRO-FLOWPartner

    Enabling Technologies and Drug Discovery: Continuous Flow Processes to Discover Novel Antiviral Inhibitors

    Horizon 2020 · 2017–2021 · Project on CORDIS ↗

  • Train2TargetPartner

    An integrated mulTidisciplinary appRoach towards a new generAtIon of aNtibiotics: Targeting function and cross-talk of bacterial Envelope proTein machineries

    Horizon 2020 · 2017–2020 · Project on CORDIS ↗

    €249ktheir share
  • COMBACTE-MAGNETPartner

    Combatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections

    FP7 (2007 to 2013) · 2015–2021 · Project on CORDIS ↗

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • antibiotic resistance
  • antibiotics
  • bacteriology
  • coronaviruses
  • critical care medicine
  • drug discovery
  • epidemics prevention
  • hepatitis B
  • liver cancer
  • medicinal chemistry
  • molecular biology
  • mortality
  • multidrug resistance
  • pandemics

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime